10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Doxorubicin (DOX) is a highly effective anti-cancer drug with limited clinical use due to its serious cardiotoxicity. Recent studies reported that erythropoietin (EPO) could exert a cardioprotective effect by non-erythropoietic effects. This study was to investigate fibrosis of DOX-induced cardiotoxicity and determine mechanisms of EPO against extracellular matrix (ECM) remodelling.

          Related collections

          Author and article information

          Journal
          Heart Lung Circ
          Heart, lung & circulation
          1444-2892
          1443-9506
          Aug 2014
          : 23
          : 8
          Affiliations
          [1 ] Department of Geriatrics, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
          [2 ] Department of Pharmacy, Guangdong Women and Children Hospital, Guangzhou 510010, China.
          [3 ] Department of Cardiology, General Hospital of Tianjin Medical University, Tianjin 300052, China.
          [4 ] Department of Geriatrics, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China. Electronic address: geriatricsxu@163.com.
          Article
          S1443-9506(14)00086-9
          10.1016/j.hlc.2014.02.015
          24685074
          0d3f0bb9-ce8d-40a4-8e9b-16bcaf435ef9
          Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
          History

          Cardiotoxicity,Doxorubicin,Erythropoietin,Fibrosis,Matrix metalloproteinase,Tissue inhibitor of metalloproteinase

          Comments

          Comment on this article